A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition

European Journal of Cancer ◽

10.1016/j.ejca.2015.08.028 ◽

2015 ◽

Vol 51 (18) ◽

pp. 2725-2731 ◽

Author(s):

G. Zucchini ◽

A.C. Armstrong ◽

A.M. Wardley ◽

G. Wilson ◽

V. Misra ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Acquired Resistance ◽

Advanced Breast ◽

Aromatase Inhibition

Download Full-text

Abstract P2-14-06: A phase II trial of low dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to an aromatase inhibitor.

10.1158/0008-5472.sabcs12-p2-14-06 ◽

2012 ◽

Author(s):

SJ Howell ◽

MW Seif ◽

AC Armstrong ◽

J Cope ◽

G Wilson ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Acquired Resistance ◽

Advanced Breast

Download Full-text

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant.

10.1158/0008-5472.sabcs-6131 ◽

2009 ◽

Author(s):

E Mrozek ◽

LJ Schaaf ◽

B Ramaswamy ◽

D Shiels ◽

L Houton ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Trial ◽

Pharmacokinetic Interaction ◽

Advanced Breast

Download Full-text

Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial

Annals of Oncology ◽

10.1093/annonc/mdu015 ◽

2014 ◽

Vol 25 (4) ◽

pp. 831-836 ◽

Author(s):

J. Bines ◽

R. Dienstmann ◽

R.M. Obadia ◽

L.G.P. Branco ◽

D.C. Quintella ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Megestrol Acetate

Download Full-text

Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

The Journal of Steroid Biochemistry and Molecular Biology ◽

10.1016/0960-0760(90)90459-x ◽

1990 ◽

Vol 37 (6) ◽

pp. 1013-1019 ◽

Author(s):

P.F. Bruning ◽

J.M.G. Bonfrèr ◽

J. Wildiers ◽

J. Jassem ◽

L.V.A.M. Beex ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Advanced Breast ◽

Endocrine Treatment ◽

Second Line ◽

Randomized Phase Ii

Download Full-text

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Annals of Oncology ◽

10.1093/annonc/mdl341 ◽

2007 ◽

Vol 18 (1) ◽

pp. 64-69 ◽

Author(s):

L. Perey ◽

R. Paridaens ◽

H. Hawle ◽

K. Zaman ◽

F. Nolé ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Aromatase Inhibitors ◽

Clinical Benefit ◽

Acquired Resistance ◽

Advanced Breast ◽

Clinical Cancer Research

Download Full-text

Faculty Opinions recommendation of Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1089398.543638 ◽

2007 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Aromatase Inhibitors ◽

Clinical Benefit ◽

Acquired Resistance ◽

Advanced Breast ◽

Clinical Cancer Research

Download Full-text

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

Acta Oncologica ◽

10.1080/02841860600897868 ◽

2007 ◽

Vol 46 (2) ◽

pp. 208-213 ◽

Author(s):

Herbert Ulrich-Pur ◽

Gabriela V. Kornek ◽

Karin Haider ◽

Werner Kwasny ◽

Thomas Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Pretreated Patients

Download Full-text

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

Oncology Research and Treatment ◽

10.1159/000216014 ◽

1986 ◽

Vol 9 (4) ◽

pp. 236-238 ◽

Author(s):

H.-E. Wander ◽

D. Meyer ◽

P. Schuff-Werner ◽

G.A. Nagel

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast

Download Full-text

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

Annals of Oncology ◽

10.1093/annonc/mdh048 ◽

2004 ◽

Vol 15 (2) ◽

pp. 201-206 ◽

Author(s):

R. Colomer ◽

A. Llombart-Cussac ◽

A. Lluch ◽

A. Barnadas ◽

B. Ojeda ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Predictive Value ◽

Phase Ii Trial ◽

Extracellular Domain ◽

Advanced Breast

Download Full-text

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(87)91392-6 ◽

1987 ◽

Vol 28 ◽

pp. 100

Author(s):

G. Mathe ◽

R. Helling ◽

J. Gastlaburu ◽

M.L.. VoVan ◽

G. Prévot ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Download Full-text